| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918086 | Radiotherapy and Oncology | 2015 | 5 Pages |
Abstract
Dose escalation to 48Â Gy in 4 fractions has been achieved successfully without dose-limiting toxicities. A planned extension of this phase I trial is currently underway treating patients to 60Â Gy in 3 fractions to further evaluate this experimental therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Lee Ponsky, Simon S. Lo, Yuxia Zhang, Mark Schluchter, Yiying Liu, Ravi Patel, Robert Abouassaly, Scott Welford, Vikas Gulani, John Robert Haaga, Mitchell Machtay, Rodney J. Ellis,